UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027758
Receipt number R000031808
Scientific Title Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for resectable and borderline resectable pancreatic cancer: Phase II study
Date of disclosure of the study information 2017/06/14
Last modified on 2019/12/16 18:46:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for resectable and borderline resectable pancreatic cancer: Phase II study

Acronym

GEM/nabPTX CRT for advanced pancreatic cancer

Scientific Title

Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for resectable and borderline resectable pancreatic cancer: Phase II study

Scientific Title:Acronym

GEM/nabPTX CRT for advanced pancreatic cancer

Region

Japan


Condition

Condition

pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic surgery Vascular surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective of this trial is to evaluate the treatment efficacy and safety of gemcitabine plus nab-paclitaxel and concurrent radiation therapy for resectable and borderline resectable pancreatic cancer as a preoperative treatment.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Overall survival

Key secondary outcomes

Disease free survival, Response (either radiological or pathological), R0 resection rate, safety, pattern of recurrence


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Induction chemotherapy with GEM/nPTX followed by GEM/nPTX CRT as a preoperative treatment for 3 months.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Patients with resectable and borderline resecable pancreatic cancer (JPS-T3/4)
(2) PS(ECOG):0 or 1
(3) Adequate bone marrow reserves, liver/renal function:
WBC:>=3,500/mm3, <=12,000/mm3
Neutrophil: >=1,500/mm3
platelet: >=100,000/mm3
Hb: >=9.5g/dL
GOT,GPT,ALP: less than 2.5-fold of the upper limit of normal range
TBil: <=1.5mg/dL
Cr: <=1.2ng/dL
Ccr: >=50ml/min
(4) Life expectancy more than 6 months.
(5) Written informed consent.

Key exclusion criteria

(1)evident infection
(2)Lung fibrosis or intestinal pneumonia, and anamnesis or imaging findings.
(3)Severe complication(liver cirrhosis, uncontrolled diabetes etc)
(4)the onset of myocardial infarction within 3 months
(5)active synchronous malignancy
(6) Pregnant or lactation women, or women with known or suspected pregnancy and men who want let to pregnancy
(7)history of severe drug allergy
(8)neuropathy
(9)patients who are judged inappropriate for the entry of the trial by the investigators

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Hidenori
Middle name
Last name Takahashi

Organization

Osaka International Cancer Institute

Division name

Gastroenterological Surgery

Zip code

541-8567

Address

3-1-69, Ohtemae, Chuo-ku, Osaka City, Japan

TEL

0669451181

Email

takahasi-hi@mc.pref.osaka.jp


Public contact

Name of contact person

1st name Hidenori
Middle name
Last name Takahashi

Organization

Dept. Surgery, Osaka International Cancer Institute

Division name

Gastroenterological Surgery

Zip code

541-8567

Address

3-1-69, Ohtemae, Chuo-ku, Osaka City, Japan

TEL

0669451181

Homepage URL


Email

takahasi-hi@mc.pref.osaka.jp


Sponsor or person

Institute

Department of Gastroenterological Surgery, Osaka International Cancer Institute

Institute

Department

Personal name



Funding Source

Organization

Osaka International Cancer Institute

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka International Cancer Institute

Address

3-1-69, Otemae, Chuo-ku, Osaka City

Tel

06-6945-1181

Email

rinri01@opho.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪国際がんセンター(大阪府)


Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 03 Month 31 Day

Date of IRB

2017 Year 03 Month 31 Day

Anticipated trial start date

2017 Year 06 Month 01 Day

Last follow-up date

2022 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 06 Month 14 Day

Last modified on

2019 Year 12 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031808


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name